Höllein A - Search Results

1

CDK6 Antagonizes p53-Induced Responses during Tumorigenesis.

Bellutti F, Tigan AS, Nebenfuehr S, Dolezal M, Zojer M, Grausenburger R, Hartenberger S, Kollmann S, Doma E, Prchal-Murphy M, Uras IZ, Höllein A, Neuberg DS, Ebert BL, Ringler A, Mueller AC, Loizou JI, Hinds PW, Vogl C, Heller G, Kubicek S, Zuber J, Malumbres M, Farlik M, Villunger A, Kollmann K, Sexl V. Bellutti F, et al. Among authors: hollein a. Cancer Discov. 2018 Jul;8(7):884-897. doi: 10.1158/2159-8290.CD-17-0912. Epub 2018 Jun 13. Cancer Discov. 2018. PMID: 29899063 Free PMC article.

2

The combination of WGS and RNA-Seq is superior to conventional diagnostic tests in multiple myeloma: Ready for prime time?

Höllein A, Twardziok SO, Walter W, Hutter S, Baer C, Hernandez-Sanchez JM, Meggendorfer M, Haferlach T, Kern W, Haferlach C. Höllein A, et al. Cancer Genet. 2020 Apr;242:15-24. doi: 10.1016/j.cancergen.2020.01.001. Epub 2020 Jan 11. Cancer Genet. 2020. PMID: 31980417 Free article.

3

NPM1 mutated AML can relapse with wild-type NPM1: persistent clonal hematopoiesis can drive relapse.

Höllein A, Meggendorfer M, Dicker F, Jeromin S, Nadarajah N, Kern W, Haferlach C, Haferlach T. Höllein A, et al. Blood Adv. 2018 Nov 27;2(22):3118-3125. doi: 10.1182/bloodadvances.2018023432. Blood Adv. 2018. PMID: 30455361 Free PMC article.

4

Molecular characterization of AML with RUNX1-RUNX1T1 at diagnosis and relapse reveals net loss of co-mutations.

Höllein A, Nadarajah N, Meggendorfer M, Jeromin S, Kern W, Haferlach C, Haferlach T. Höllein A, et al. Hemasphere. 2019 Feb 4;3(1):e178. doi: 10.1097/HS9.0000000000000178. eCollection 2019 Feb. Hemasphere. 2019. PMID: 31723813 Free PMC article.

5

Minimal residual disease (MRD) monitoring and mutational landscape in AML with RUNX1-RUNX1T1: a study on 134 patients.

Höllein A, Jeromin S, Meggendorfer M, Fasan A, Nadarajah N, Kern W, Haferlach C, Haferlach T. Höllein A, et al. Leukemia. 2018 Oct;32(10):2270-2274. doi: 10.1038/s41375-018-0086-0. Epub 2018 Mar 6. Leukemia. 2018. PMID: 29568097 No abstract available.

6

Indeterminate and oncogenic potential: CHIP vs CHOP mutations in AML with NPM1 alteration.

Cappelli LV, Meggendorfer M, Baer C, Nadarajah N, Hutter S, Jeromin S, Dicker F, Kern W, Haferlach T, Haferlach C, Höllein A. Cappelli LV, et al. Among authors: hollein a. Leukemia. 2022 Feb;36(2):394-402. doi: 10.1038/s41375-021-01368-1. Epub 2021 Aug 10. Leukemia. 2022. PMID: 34376804 Free PMC article.

7

DNMT3A mutations are over-represented in young adults with NPM1 mutated AML and prompt a distinct co-mutational pattern.

Cappelli LV, Meggendorfer M, Dicker F, Jeromin S, Hutter S, Kern W, Haferlach T, Haferlach C, Höllein A. Cappelli LV, et al. Among authors: hollein a. Leukemia. 2019 Nov;33(11):2741-2746. doi: 10.1038/s41375-019-0502-0. Epub 2019 Jun 17. Leukemia. 2019. PMID: 31209279 No abstract available.

8

Molecular characterization of a second myeloid neoplasm developing after treatment for acute myeloid leukemia.

Hartmann L, Nadarajah N, Meggendorfer M, Höllein A, Vetro C, Kern W, Haferlach T, Haferlach C, Stengel A. Hartmann L, et al. Among authors: hollein a. Leukemia. 2020 Mar;34(3):811-820. doi: 10.1038/s41375-019-0633-3. Epub 2019 Nov 12. Leukemia. 2020. PMID: 31719678

9

Hematologist-Level Classification of Mature B-Cell Neoplasm Using Deep Learning on Multiparameter Flow Cytometry Data.

Zhao M, Mallesh N, Höllein A, Schabath R, Haferlach C, Haferlach T, Elsner F, Lüling H, Krawitz P, Kern W. Zhao M, et al. Among authors: hollein a. Cytometry A. 2020 Oct;97(10):1073-1080. doi: 10.1002/cyto.a.24159. Epub 2020 Jun 9. Cytometry A. 2020. PMID: 32519455 Free article.

10

Inhibition of PLK1 by capped-dose volasertib exerts substantial efficacy in MDS and sAML while sparing healthy haematopoiesis.

Dill V, Kauschinger J, Hauch RT, Buschhorn L, Odinius TO, Müller-Thomas C, Mishra R, Kyncl MC, Schmidt B, Prodinger PM, Hempel D, Bellos F, Höllein A, Kern W, Haferlach T, Slotta-Huspenina J, Bassermann F, Peschel C, Götze KS, Waizenegger IC, Höckendorf U, Jost PJ, Jilg S. Dill V, et al. Among authors: hollein a. Eur J Haematol. 2020 Feb;104(2):125-137. doi: 10.1111/ejh.13354. Epub 2019 Dec 8. Eur J Haematol. 2020. PMID: 31758597 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

15 results

Search Page

Filters